REMINDER: Our user survey closes on Friday, please submit your responses here.
Numerous at home antigen tests? No, there are not that many. There is one from Sona and another one in development by Avacta.
RD.
Thanks for the links.
Understood that Affimer technology has multifaceted potential, it is why I am invested here and long. I made a statement of the facts as we know them - that at the moment Avacta are not in development of any cancer diagnostics currently not have they announced any near term intent to do so. It isn't 'highly likely' at the present time as stated in the OP's statement, potential notwithstanding.
The field of 'liquid biopsy'...Testing blood as a non invasive way to diagnose and monitor cancers (and potentially stage, monitor for metastasis and for the effectiveness of treatment) is a newish field of research yet to become fully established and is estimated to be a $300b market globally. Avacta are not in this field of research at the current time. Possible one day but the time lines they have announced for all other projects seem to preclude in the medium term.
Interestingly and as an aside our AVCT strategic investor has a 7% stake in another UK co who could potentially lead the field in liquid biopsy and who currently have an FDA application pending.
http://www.labnews.co.uk/article/2030687/more-gain-less-pain-with-liquid
Interesting indeed and for disclosure i hold there also.
RK "it is more than possible that Affirmers could be used for diagnostics in oncology. This would speed up the opportunity to treat a patient. The company have not given anything of this away at this point, but it must be a strong possibility"
As you say the company have made no mention nor alluded to it in any way, it is conjecture and speculation on your part. I think Avacta have enough strings to their bow which support a rational for investment.
I don't think one needs to invent more or speculate further from the available evidence base.
Also sent, thanks for the draft.
Email is market.abuse@fca.org.uk
It's back now I think on IG, I couldn't get a quote earlier.
*vigilant!!
Most of us invested in OSX's diagnostic test for antibodies on the premise that our government and others will buy said test because it is useful for a whole raft of reasons.
As an investor I want to know the science bit, the investment case and the contrarian view. Don't dismiss a published study in Nature because it's from China? There is a global science led effort to understand this virus. The ODX test is being used in Ulster ATM to establish the usefulness of antibodies re immunity short, medium and long term on 3000 people. Would they do that if they had every confidence in antibody testing long term already? It's not established yet, that is the position ATM. Of course that affects the investment case in the medium to long term. In the short term I believe we will see a significant increase in SP but in AIM, with government led contracts and in this climate I think you have to be very violent and protect you capital. DYOR and GL
That new study is troubling. The immunity question remains. Please do throw out other data or studies which counter this, I want to know more and for clarification I did sell my holding today.
Here is the synopsis from the Forbes article which interprets the Nature pub, please remember that Nature is a very respected science publication.
This is prescient information and I think the case re antibody tests is still NOT fully established.
"One purpose of the study was to measure the duration of the antibody response following infection in both the asymptomatic and symptomatic groups. The levels of Both IgG and IgM antibodies were measured 3-4 weeks post initial detection of infection and for two months thereafter.
These are the most consequential results of this study. The finding that some people infected with SARS-CoV-2 infection do not make antibodies, added to the observation that neutralizing antibodies begin to drop noticeably a few weeks post-infection, raises the possibility that infection by SARS-CoV-2 does not establish long-lasting immunity, at least for those without symptoms or only mildly ill, more than 80% of all those infected by SARS-CoV-2 "
Read that today in Nature and this from Forbes about that data study, made it easier for me to understand.
https://www.forbes.com/sites/williamhaseltine/2020/06/19/immunity-to-covid-19-infection-may-fade-quickly/
I've held ODX since mid April From the low 40's in a Barclays account, I called them and they said they didn't support placings, in effect precluding me from the 5% shares I would of purchased plus hoping for another tranche of the open offer if I could get any.....
I got very irritated about that and decided to sell my holding of 36k shares and took profit at 53 today. I'll chance it in the mele of next weeks market to perhaps get in lower but appreciate I may have shot myself in the foot IF the RNS arrives.
I have a couple of broker accounts (the other with II) but today illustrated to me again that Barclays are bloody awful (I used to work for them at Barclays Stockbrokers some years ago when I'd say they were best retail broker out there).
I'll take some time this weekend to evaluate and research. I'm uncomfortable with some of the papers I've read re antibody presentation and time they are (Nature Mag) present for post infection and so want to dig into that for obvious reasons.
One thing I learnt today was to check your broker supports the obvious facilities you need to hold AIM shares.
GLA
I called Barclays today and they were unhelpful and said that they didn't offer placing services. I am going to check further because I spoke to someone who seemed quite clueless. Give them a call.
I've had three tests so far for Covid as part of the studies from Kings, Imperial and PHE because I signed up.
Some good data now being published.
This data is coming from a study from Kings and PHE with 3 million plus daily reporting on the app.
They launched their daily data tracker and have extrapolated data for likely new infections and current levels
in the UK nationally and regionally in this site this week. Good for real-time tracking of Covid
https://covid.joinzoe.com/
This data is coming from a study from Kings and PHE. I've been a part of daily reporters using there app from launch in March, there are 3 million plus participants in the UK and I've had three home swab tests to date as a part of the research (very unpleasant).
They launched their daily extrapolated data in this site this week.
https://covid.joinzoe.com/
Wow.
https://twitter.com/buy_buy_bye/status/1270786603590565890?s=19
Worth a listen to More or Less the radio 4 statistics programme. This one's on antibody tests and the woeful initial test data behind them and how big pharma have talked up and about 100% accuracy based on the results of a few people (9) and the discounted data of thousands.
Also discusses sufficient antibody level in the body and what level register in the tests post infection.
The tests the UK are currently using from Abbottt and Roche are based on very small numbers of people to establish their accuracy, specificity and sensitivity.
It's clear when ODX get the test out IF it picks up a smaller level of present antibodies and the data set is robust it will hands down lead the field.
httpss://www.bbc.co.uk/sounds/play/m000jw02
Suggest you look/monitor to buy in after any potential initial 'news' spike.
Can get a quote for £1 to buy
Bump, BB gold.
Amongst all the bragging and bleeding noise on the BB this is (imo) the most useful, informed and rational thread for some time.
Thanks, not got a specialist knowledge but appreciate those who do and share it.
Getting burnt. :)